Literature DB >> 33562096

Cancer-Associated Fibroblast Subgroups Showing Differential Promoting Effect on HNSCC Progression.

Soo Hyun Kang1, Su Young Oh1, Heon-Jin Lee1, Tae-Geon Kwon2, Jin-Wook Kim2, Sung-Tak Lee2, So-Young Choi2, Su-Hyung Hong1.   

Abstract

Background: The critical effect of the tumor microenvironment on cancer progression is well recognized. Recent research suggests that the cancer-promoting properties of the tumor stroma may be attributed to fibroblasts. However, the effect of cancer-associated fibroblast (CAF) on the progression of head and neck squamous cell carcinoma (HNSCC) is not well known.
Methods: From the immunohistochemical analysis of head and neck squamous cell carcinoma (HNSCC) tissues, we divided CAF into two groups depending on the presence or absence of a well-demarcated boundary between epithelial cancer cells and the surrounding extracellular matrix (ECM). Primary culture of CAF was performed, followed by co-transplantation with HNSCC cells into mice oral mucosa, and the tumorigenesis was compared. The mRNA expression patterns between these two CAF groups were compared using DNA microarray analysis.
Results: CAFs from cancer tissues that showed no demarcation between ECM and epithelial cancer cells (CAF-Promote) tended to stimulate Matrigel invasion of HNSCC cells. Conversely, CAFs from cancer tissues that showed a boundary with epithelial cancer cells (CAF-Delay) caused no remarkable increase in Matrigel invasion. Compared with CAF-P, CAF-D is less effective in promoting FaDu tumorigenicity in the mouse model. In DNA microarray analysis, COL3A1 and COL6A6 showed particularly high expression in the CAF-D group. Conclusions: These cancer stroma-derived collagen proteins might delay the HNSCC progression. These findings are expected to provide vital information for predicting HNSCC prognosis and developing drug targets in the future.

Entities:  

Keywords:  DNA microarray; cancer-associated fibroblast; collagen; head and neck squamous cell carcinoma

Year:  2021        PMID: 33562096      PMCID: PMC7915931          DOI: 10.3390/cancers13040654

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  52 in total

1.  The phenotype of cancer cell invasion controlled by fibril diameter and pore size of 3D collagen networks.

Authors:  Jiranuwat Sapudom; Stefan Rubner; Steve Martin; Tony Kurth; Stefanie Riedel; Claudia T Mierke; Tilo Pompe
Journal:  Biomaterials       Date:  2015-03-03       Impact factor: 12.479

2.  Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway.

Authors:  Po-Hao Chang; Wendy W Hwang-Verslues; Yi-Cheng Chang; Chun-Chin Chen; Michael Hsiao; Yung-Ming Jeng; King-Jen Chang; Eva Y-H P Lee; Jin-Yuh Shew; Wen-Hwa Lee
Journal:  Cancer Res       Date:  2012-07-23       Impact factor: 12.701

Review 3.  Hallmarks of cancer: interactions with the tumor stroma.

Authors:  Kristian Pietras; Arne Ostman
Journal:  Exp Cell Res       Date:  2010-03-06       Impact factor: 3.905

4.  High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts.

Authors:  Emilie Flaberg; Laszlo Markasz; Gabor Petranyi; Gyorgy Stuber; Ferenc Dicso; Nidal Alchihabi; Èva Oláh; István Csízy; Tamás Józsa; Ove Andrén; Jan-Erik Johansson; Swen-Olof Andersson; George Klein; Laszlo Szekely
Journal:  Int J Cancer       Date:  2010-12-29       Impact factor: 7.396

5.  A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.

Authors:  Ivo J Huijbers; Marjan Iravani; Sergey Popov; David Robertson; Safa Al-Sarraj; Chris Jones; Clare M Isacke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

6.  Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts.

Authors:  L J A C Hawinkels; M Paauwe; H W Verspaget; E Wiercinska; J M van der Zon; K van der Ploeg; P J Koelink; J H N Lindeman; W Mesker; P ten Dijke; C F M Sier
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

7.  Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts.

Authors:  Andrea Sadlonova; Damon B Bowe; Zdenek Novak; Shibani Mukherjee; Virginia E Duncan; Grier P Page; Andra R Frost
Journal:  Cancer Microenviron       Date:  2009-03-18

8.  Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts.

Authors:  M G Stoker; M Shearer; C O'Neill
Journal:  J Cell Sci       Date:  1966-09       Impact factor: 5.285

9.  Modulated expression of WFDC1 during carcinogenesis and cellular senescence.

Authors:  Shalom Madar; Ran Brosh; Yosef Buganim; Osnat Ezra; Ido Goldstein; Hilla Solomon; Ira Kogan; Naomi Goldfinger; Helmut Klocker; Varda Rotter
Journal:  Carcinogenesis       Date:  2008-10-08       Impact factor: 4.944

10.  COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway.

Authors:  Ruiqing Long; Zhuohui Liu; Jinghui Li; Hualin Yu
Journal:  Aging (Albany NY)       Date:  2019-10-17       Impact factor: 5.682

View more
  2 in total

1.  Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts.

Authors:  Shaofei Liu; Yasir Suhail; Ashkan Novin; Lorrie Perpetua
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.

Authors:  Jinjin Chen; Surong Chen; Xichao Dai; Liang Ma; Yu Chen; Weigang Bian; Yunhao Sun
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.